Nimodipine: Side Effects, Uses & Monitoring
Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardle
- Data source
- FDA labeling via NIH DailyMed (label e65d5108…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
| Adverse reaction (as reported in labeling) | Reported frequency* |
|---|---|
| Decreased blood pressure | 0% |
| Abnormal liver function test | 0% |
| Edema | 0% |
| Diarrhea | 0% |
| Rash | 0% |
| Headache | 0% |
| Gastrointestinal symptoms | 0% |
| Nausea | 0% |
| Dyspnea | 0% |
| Ekg abnormalities | 0% |
| Tachycardia | 0% |
| Bradycardia | 0% |
| Muscle pain/cramp | 0% |
| Acne | 0% |
| Depression | 0% |
*Highest percentage reported for the active moiety across placebo-controlled trial tables in current FDA labeling. Values reflect trial reporting, not your individual risk.
Labeled uses (from FDA prescribing information)
Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).
Frequently Asked Questions
What is Nimodipine used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Nimodipine?
The table above shows adverse reactions and the highest frequencies reported in placebo-controlled trials summarized in current FDA labeling for Nimodipine. Individual risk varies.
Does Nimodipine require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Nimodipine.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.